Price to Sales ratio Analysis of Corvus Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PS
Period Ending - Dec-23
Very Poor PS
0
Period Ending - Dec-22
Very Poor PS
0
Growth
0 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
107820
PS Analysis of Corvus Pharmaceuticals Inc
| P/S Ratio of Corvus Pharmaceuticals Inc with value of 107820 indicates that stock price is high compared to sales of the company and may be overvalued. |
| PS Ratio of CRVS has fallen by 0 % Compared to previous Financial Year. |
| PS Ratio with value of 0 was highest in Year Dec-23 in last Five Years. |
| PS Ratio of CRVS trending down for at least three Years. |
| Latest PS Ratio with value of 0 is lower than Average PS of 0 in last five years. |
Other PS Related Info of CRVS that may interest you.
Corvus Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| CRVS | 2.16 | 2.11 | 2.37 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..
PS Related Ratios
| PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Price to Sales of Corvus Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| PS | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change |
FY Chart of Price to Sales of Corvus Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)